Comprehensive genomic profiling with industry-leading 1000x coverage.
The test can be performed on liquid biopsy (blood) or tumor (FFPE).
Report will give treatment options.
Superior accuracy by testing both cancerous tumor DNA and healthy DNA.
A study at John Hopkins University found tumor-normal match testing provides 31% better accuracy by reducing false positive and false negative results*
Our brochure explains in detail the benefits of the test as well as what is included.
Your report will include:
Puja Mehra2nd stage colon cancer
Rohini C. 1st stage breast cancer
PositiveSelect Match is the one stop solution to test possible options for your cancer treatment. The report will give you treatment options.
Our experts and doctors are happy to guide you.